Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search span> per sponsor: gsk
Woman and Man Max 99 years
gsk
Update Il y a 5 ans
An integrated review to evaluate dose response of umeclidinium (GSK573719) administered once or twice daily in Subjects with COPD
The purpose of this study was to assess the total daily dose response of umeclidinium using pooled data from study AC4113073 and AC4115321 (excluding the site with Investigator ID of 040688) following...
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
An open-label multicentre, randomised, phase II comparator study of oral topotecan versus intravenous topotecan for second-line therapy in sensitive patients with small cell lung cancer
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
gsk
Update Il y a 5 ans
PRJ2203: A Prospective Observational Cohort Study to Monitor Occurrence of Hypersensitivity Reaction and Hepatotoxicity in Patients Receiving Dolutegravir
Dolutegravir (DTG) is recommended for both treatment-naïve and treatment-experienced, HIV infected adults and paediatric patients aged 12 years and older and weighing at least 40 kg. One case of suspe...
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A multicentre, double-blind, parallel group, randomised dose study comparing the efficacy of paroxetine 20mg increasing to 30mg daily if there is insufficient response and clomipramine 60mg increasing to 75mg daily, in outpatients (age >60 years) with moderate depression according to…
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A Long-Term Extension of a Double-Blind, Placebo -Controlled Comparative Study of Paroxetine and Clomipramine in the Treatment of Panic Disorder
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Waterpipe use in the Middle East and North Africa: analysis of the BREATHE study
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A Phase I Study to Determine the Maximum Tolerated Dose of Topotecan Following Oral Administration over 5, 10 or 21 Days in Patients with Malignant Solid Tumors
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
The long-term use of Advair/Seretide and risk of events (incident non-vertebral fracture, glaucoma, and cataracts) among COPD patients in the UK General Research Practice Database
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
An investigation of the pharmacokinetics, efficacy, and tolerance of paroxetine in geriatric patients with depression
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A double-blind, placebo-controlled multi-centre study to evaluate the efficacy and tolerability of Paroxetine in the treatment of post-stroke depression
Country
None
organs
None
Specialty
None
Closed trial
More information
1
2
3
4
5
6
7
8
9
10
Next